Omnicell Names Nnamdi Njoku as Executive Vice President and Chief Operating Officer

Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming pharmacy care delivery, has announced the appointment of Nnamdi Njoku as Executive Vice President and Chief Operating Officer, effective October 7, 2024. In this newly created role, Njoku will report directly to Randall Lipps, Omnicell’s chairman, president, CEO, and founder, and will oversee the company’s global operations.

Njoku brings nearly 25 years of experience in leading operations at major healthcare and medical technology organizations. Most recently, he served as President of Sports Medicine, Surgical, Upper Extremities, and Restorative Therapies at Zimmer Biomet Holdings, Inc. Prior to this, he spent over 18 years at Medtronic plc, where he led the Neuromodulation Operating Unit, a $2 billion business focused on using neuromodulation to treat pain and movement disorders. His career also includes leadership roles at UnitedHealth Group and Deloitte Consulting.

“We are excited to welcome Nnamdi to Omnicell in this key role,” said Lipps. “His reputation in the med tech industry is exceptional, and his combination of values-based leadership and operational expertise will be vital to our future. We believe his passion for using technology to improve healthcare and his strategic insights will help drive Omnicell’s continued success.”

Njoku expressed his enthusiasm for joining Omnicell at a pivotal moment in the company’s history. “Omnicell has a strong track record of innovative solutions aimed at addressing key issues in medication management,” he said. “I am inspired by the company’s focus on outcomes-driven innovation and look forward to working with Randall and the Omnicell team to enhance the future of pharmacy care and improve patient outcomes.

About Nnamdi Njoku

Prior to joining Omnicell, Mr. Njoku served as President – Sports Medicine, Surgical, Upper Extremities and Restorative Therapies of Zimmer Biomet Holdings, Inc., a global medical technology leader. Prior to Zimmer Biomet, Mr. Njoku served in various executive and operational leadership roles at Medtronic plc. Prior to Medtronic, Mr. Njoku worked in operational and corporate finance roles at UnitedHealth Group, and began his career at Deloitte Consulting, helping clients optimize their operations. Mr. Njoku served as Vice Chair of People’s Center Healthcare Services, a nationally recognized community health center serving diverse communities in the Minneapolis, Minn. area. He currently sits on the board for the Children’s Theatre Company, the nation’s largest and most acclaimed theatre for young people that serves a multigenerational audience. Mr. Njoku earned a Master of Business Administration from Cornell University and a Bachelor of Arts degree in Business Administration from the University of St. Thomas. He is a Fellow of the fourth class of Aspen Institute’s Health Innovators Fellowship, a member of the Aspen Global Leadership Network.

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter